Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy

Samankaltaisia teoksia

• Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse
  Tekijä: Onesti, Concetta Elisa, et al.
  Julkaistu: (2020)
• Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
  Tekijä: Onesti, Concetta Elisa, et al.
  Julkaistu: (2018)
• Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers
  Tekijä: Latgé, Guillaume, et al.
  Julkaistu: (2018)
• Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients
  Tekijä: Frères, Pierre, et al.
  Julkaistu: (2018)
• Atypical patterns of response to immune checkpoint inhibitors: interpreting pseudoprogression and hyperprogression in decision making for patients’ treatment
  Tekijä: Onesti, Concetta Elisa, et al.
  Julkaistu: (2019)